GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Prism Biolab Co Ltd (TSE:206A) » Definitions » EPS (Basic)

Prism Biolab Co (TSE:206A) EPS (Basic) : 円-35.02 (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Prism Biolab Co EPS (Basic)?

Prism Biolab Co's basic earnings per share (Basic EPS) for the six months ended in Mar. 2025 was 円-13.06. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was 円-35.02.

Prism Biolab Co's EPS (Diluted) for the six months ended in Mar. 2025 was 円-13.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was 円-35.02.

Prism Biolab Co's EPS without NRI for the six months ended in Mar. 2025 was 円-12.20. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -29.80.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Prism Biolab Co EPS (Basic) Historical Data

The historical data trend for Prism Biolab Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prism Biolab Co EPS (Basic) Chart

Prism Biolab Co Annual Data
Trend Sep22 Sep23 Sep24
EPS (Basic)
2.51 -19.09 -33.53

Prism Biolab Co Semi-Annual Data
Sep22 Sep23 Mar24 Sep24 Mar25
EPS (Basic) - - -11.57 -21.96 -13.06

Prism Biolab Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Prism Biolab Co's Basic EPS for the fiscal year that ended in Sep. 2024 is calculated as

Basic EPS (A: Sep. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1049.514-0)/31.304
=-33.53

Prism Biolab Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-474.387-0)/36.335
=-13.06

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-35.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prism Biolab Co  (TSE:206A) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Prism Biolab Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Prism Biolab Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Prism Biolab Co Business Description

Traded in Other Exchanges
N/A
Address
2-26-1 Muraokahigashi, Kanagawa, Fujisawa, JPN, 251-8555
Prism Biolab Co Ltd is engaged in drug discovery and development based on PepMetics Technology, a proprietary platform technology.

Prism Biolab Co Headlines

No Headlines